| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
7,000,000 |
| Market
Cap: |
2.46(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.352 - $0.352 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile InMed Pharmaceuticals is a clinical stage pharmaceutical company engageing in the research and development of novel, cannabinoid-based therapies and an integrated system for the manufacturing of pharmaceutical-grade cannabinoids.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
79,100 |
79,100 |
79,100 |
79,100 |
| Total Buy Value |
$29,547 |
$29,547 |
$29,547 |
$29,547 |
| Total People Bought |
2 |
2 |
2 |
2 |
| Total Buy Transactions |
2 |
2 |
2 |
2 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Hull Andrew |
Director |
– • – |
2024-02-21 |
4 |
B |
$0.39 |
$14,625 |
D/D |
37,500 |
38,258 |
2.39 |
- |
|
| Adams Eric A |
President & CEO |
• • – |
2024-02-20 |
4 |
B |
$0.36 |
$14,922 |
D/D |
41,600 |
43,959 |
2.81 |
- |
|
| Adams Eric A |
President & CEO |
• • – |
2022-04-14 |
4 |
B |
$0.89 |
$12,659 |
D/D |
14,160 |
59,003 |
2.81 |
-71% |
|
| Adams Eric A |
President & CEO |
• • – |
2022-04-13 |
4 |
B |
$0.85 |
$7,276 |
D/D |
8,560 |
44,843 |
2.81 |
-68% |
|
| Colwill Bruce |
CFO |
• – – |
2022-01-24 |
4 |
B |
$1.09 |
$5,439 |
D/D |
5,000 |
11,515 |
2.74 |
-41% |
|
| Johnson Shane Aaron |
SVP, GM of BayMedica LLC |
• – – |
2022-01-06 |
4 |
B |
$1.26 |
$10,710 |
D/D |
8,500 |
304,595 |
2.74 |
-35% |
|
| Johnson Shane Aaron |
SVP, GM of BayMedica LLC |
• – – |
2021-12-30 |
4 |
B |
$1.33 |
$10,736 |
D/D |
8,093 |
296,095 |
2.74 |
-35% |
|
| Johnson Shane Aaron |
SVP, GM of BayMedica LLC |
• – – |
2021-11-15 |
4 |
B |
$1.37 |
$6,845 |
D/D |
5,000 |
288,002 |
2.74 |
-22% |
|
| Johnson Shane Aaron |
SVP & GM of BayMedica LLCOffic |
• – – |
2021-11-02 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
278,428 |
|
-54% |
|
| Johnson Shane Aaron |
SVP & GM of BayMedica LLCOffic |
• – – |
2021-11-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,574 |
|
-54% |
|
| Adams Eric A |
President & CEO |
• • – |
2021-09-29 |
4 |
B |
$1.73 |
$15,224 |
D/D |
8,800 |
36,283 |
2.81 |
-35% |
|
| Adams Eric A |
President & CEO |
• • – |
2021-09-28 |
4 |
B |
$1.75 |
$19,984 |
D/D |
11,400 |
27,483 |
2.81 |
-38% |
|
| Colwill Bruce |
CFO |
• – – |
2021-09-28 |
4 |
B |
$1.77 |
$8,840 |
D/D |
5,000 |
6,515 |
2.74 |
-38% |
|
| Colwill Bruce |
CFOOfficer |
• – – |
2020-11-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,515 |
|
8% |
|
| Garner William J |
Director |
– • – |
2020-11-12 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,788 |
|
8% |
|
| Woudenberg Michael |
VP, Chem/Manufacturing/Control |
• – – |
2020-11-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
530 |
|
8% |
|
| Mancini Alexandra Diane Janet |
Sr VP, Clinical/Reg AffairsOff |
• – – |
2020-11-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
6,061 |
|
8% |
|
| Hsu Eric C |
Sr VP, Pre-Clinical Res/DevOff |
• – – |
2020-11-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,273 |
|
8% |
|
| Hull Andrew |
Director |
– • – |
2020-11-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
18,939 |
|
8% |
|
19 Records found
|
1
|
Page 1 of 1 |
|
|
